TGFBR3L and neoplasm: TGFBR3L staining was present in 52% (n = 60) of the gonadotroph tumours, and in one double-PitNET (positive for FSHβ and SF-1 in some cells, and for ACTH and T-Pit in others), while all other tumours were negative.